Copyright Reports & Markets. All rights reserved.

Global Tigecycline Market Insights and Forecast to 2027

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Tigecycline Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Tigecycline Market Size Growth Rate by Type
    • 1.4.2 Original Drug
    • 1.4.3 Generic Drug
  • 1.3 Market by Application
    • 1.3.1 Global Tigecycline Market Size Growth Rate by Application
    • 1.3.2 Hospital Pharmacies
    • 1.3.3 Retail Pharmacies
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Executive Summary

  • 2.1 Global Tigecycline Sales Estimates and Forecasts 2016-2027
  • 2.2 Global Tigecycline Revenue Estimates and Forecasts 2016-2027
  • 2.3 Global Tigecycline Revenue by Region: 2016 VS 2021 VS 2027
  • 2.4 Global Top Tigecycline Regions by Sales
    • 2.4.1 Global Top Tigecycline Regions by Sales (2016-2021)
    • 2.4.2 Global Top Tigecycline Regions by Sales (2022-2027)
  • 2.5 Global Top Tigecycline Regions by Revenue
    • 2.5.1 Global Top Tigecycline Regions by Revenue (2016-2021)
    • 2.5.2 Global Top Tigecycline Regions by Revenue (2022-2027)
  • 2.6 North America
  • 2.7 Europe
  • 2.8 Asia-Pacific
  • 2.9 Latin America
  • 2.10 Middle East & Africa

3 Competition by Manufacturers

  • 3.1 Global Tigecycline Sales by Manufacturers
    • 3.1.1 Global Top Tigecycline Manufacturers by Sales (2016-2021)
    • 3.1.2 Global Top Tigecycline Manufacturers Market Share by Sales (2016-2021)
    • 3.1.3 Global Top 10 and Top 5 Companies by Tigecycline Sales in 2020
  • 3.2 Global Tigecycline Revenue by Manufacturers
    • 3.2.1 Global Top Tigecycline Manufacturers by Revenue (2016-2021)
    • 3.2.2 Global Top Tigecycline Manufacturers Market Share by Revenue (2016-2021)
    • 3.2.3 Global Top 10 and Top 5 Companies by Tigecycline Revenue in 2020
  • 3.3 Global Tigecycline Sales Price by Manufacturers
  • 3.4 Analysis of Competitive Landscape
    • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Tigecycline Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.4.3 Global Tigecycline Manufacturers Geographical Distribution
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global Tigecycline Sales by Type
    • 4.1.1 Global Tigecycline Historical Sales by Type (2016-2021)
    • 4.1.2 Global Tigecycline Forecasted Sales by Type (2022-2027)
    • 4.1.3 Global Tigecycline Sales Market Share by Type (2016-2027)
  • 4.2 Global Tigecycline Revenue by Type
    • 4.2.1 Global Tigecycline Historical Revenue by Type (2016-2021)
    • 4.2.2 Global Tigecycline Forecasted Revenue by Type (2022-2027)
    • 4.2.3 Global Tigecycline Revenue Market Share by Type (2016-2027)
  • 4.3 Global Tigecycline Price by Type
    • 4.3.1 Global Tigecycline Price by Type (2016-2021)
    • 4.3.2 Global Tigecycline Price Forecast by Type (2022-2027)

5 Market Size by Application

  • 5.1 Global Tigecycline Sales by Application
    • 5.1.1 Global Tigecycline Historical Sales by Application (2016-2021)
    • 5.1.2 Global Tigecycline Forecasted Sales by Application (2022-2027)
    • 5.1.3 Global Tigecycline Sales Market Share by Application (2016-2027)
  • 5.2 Global Tigecycline Revenue by Application
    • 5.2.1 Global Tigecycline Historical Revenue by Application (2016-2021)
    • 5.2.2 Global Tigecycline Forecasted Revenue by Application (2022-2027)
    • 5.2.3 Global Tigecycline Revenue Market Share by Application (2016-2027)
  • 5.3 Global Tigecycline Price by Application
    • 5.3.1 Global Tigecycline Price by Application (2016-2021)
    • 5.3.2 Global Tigecycline Price Forecast by Application (2022-2027)

6 North America

  • 6.1 North America Tigecycline Market Size by Type
    • 6.1.1 North America Tigecycline Sales by Type (2016-2027)
    • 6.1.2 North America Tigecycline Revenue by Type (2016-2027)
  • 6.2 North America Tigecycline Market Size by Application
    • 6.2.1 North America Tigecycline Sales by Application (2016-2027)
    • 6.2.2 North America Tigecycline Revenue by Application (2016-2027)
  • 6.3 North America Tigecycline Market Size by Country
    • 6.3.1 North America Tigecycline Sales by Country (2016-2027)
    • 6.3.2 North America Tigecycline Revenue by Country (2016-2027)
    • 6.3.3 U.S.
    • 6.3.4 Canada

7 Europe

  • 7.1 Europe Tigecycline Market Size by Type
    • 7.1.1 Europe Tigecycline Sales by Type (2017-2027)
    • 7.1.2 Europe Tigecycline Revenue by Type (2017-2027)
  • 7.2 Europe Tigecycline Market Size by Application
    • 7.2.1 Europe Tigecycline Sales by Application (2017-2027)
    • 7.2.2 Europe Tigecycline Revenue by Application (2017-2027)
  • 7.3 Europe Tigecycline Market Size by Country
    • 7.3.1 Europe Tigecycline Sales by Country (2017-2027)
    • 7.3.2 Europe Tigecycline Revenue by Country (2017-2027)
    • 7.3.3 Germany
    • 7.3.4 France
    • 7.3.5 U.K.
    • 7.3.6 Italy
    • 7.3.7 Russia

8 Asia Pacific

  • 8.1 Asia Pacific Tigecycline Market Size by Type
    • 8.1.1 Asia Pacific Tigecycline Sales by Type (2018-2027)
    • 8.1.2 Asia Pacific Tigecycline Revenue by Type (2018-2027)
  • 8.2 Asia Pacific Tigecycline Market Size by Application
    • 8.2.1 Asia Pacific Tigecycline Sales by Application (2018-2027)
    • 8.2.2 Asia Pacific Tigecycline Revenue by Application (2018-2027)
  • 8.3 Asia Pacific Tigecycline Market Size by Region
    • 8.3.1 Asia Pacific Tigecycline Sales by Region (2018-2027)
    • 8.3.2 Asia Pacific Tigecycline Revenue by Region (2018-2027)
    • 8.3.3 China
    • 8.3.4 Japan
    • 8.3.5 South Korea
    • 8.3.6 India
    • 8.3.7 Australia
    • 8.3.8 Taiwan
    • 8.3.9 Indonesia
    • 8.3.10 Thailand
    • 8.3.11 Malaysia

9 Latin America

  • 9.1 Latin America Tigecycline Market Size by Type
    • 9.1.1 Latin America Tigecycline Sales by Type (2019-2027)
    • 9.1.2 Latin America Tigecycline Revenue by Type (2019-2027)
  • 9.2 Latin America Tigecycline Market Size by Application
    • 9.2.1 Latin America Tigecycline Sales by Application (2019-2027)
    • 9.2.2 Latin America Tigecycline Revenue by Application (2019-2027)
  • 9.3 Latin America Tigecycline Market Size by Country
    • 9.3.1 Latin America Tigecycline Sales by Country (2019-2027)
    • 9.3.2 Latin America Tigecycline Revenue by Country (2019-2027)
    • 9.3.3 Mexico
    • 9.3.4 Brazil
    • 9.3.5 Argentina

6 Middle East and Africa

  • 6.1 Middle East and Africa Tigecycline Market Size by Type
    • 6.1.1 Middle East and Africa Tigecycline Sales by Type (2016-2027)
    • 6.1.2 Middle East and Africa Tigecycline Revenue by Type (2016-2027)
  • 6.2 Middle East and Africa Tigecycline Market Size by Application
    • 6.2.1 Middle East and Africa Tigecycline Sales by Application (2016-2027)
    • 6.2.2 Middle East and Africa Tigecycline Revenue by Application (2016-2027)
  • 6.3 Middle East and Africa Tigecycline Market Size by Country
    • 6.3.1 Middle East and Africa Tigecycline Sales by Country (2016-2027)
    • 6.3.2 Middle East and Africa Tigecycline Revenue by Country (2016-2027)
    • 6.3.3 Turkey
    • 6.3.4 Saudi Arabia
    • 6.3.5 UAE

11 Company Profiles

  • 11.1 Pfizer (Wyeth)
    • 11.1.1 Pfizer (Wyeth) Corporation Information
    • 11.1.2 Pfizer (Wyeth) Overview
    • 11.1.3 Pfizer (Wyeth) Tigecycline Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.1.4 Pfizer (Wyeth) Tigecycline Product Description
    • 11.1.5 Pfizer (Wyeth) Related Developments
  • 11.2 Sino Biopharmaceutical
    • 11.2.1 Sino Biopharmaceutical Corporation Information
    • 11.2.2 Sino Biopharmaceutical Overview
    • 11.2.3 Sino Biopharmaceutical Tigecycline Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.2.4 Sino Biopharmaceutical Tigecycline Product Description
    • 11.2.5 Sino Biopharmaceutical Related Developments
  • 11.3 Zhejiang Hisun Pharma
    • 11.3.1 Zhejiang Hisun Pharma Corporation Information
    • 11.3.2 Zhejiang Hisun Pharma Overview
    • 11.3.3 Zhejiang Hisun Pharma Tigecycline Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.3.4 Zhejiang Hisun Pharma Tigecycline Product Description
    • 11.3.5 Zhejiang Hisun Pharma Related Developments
  • 11.4 Jiangsu Hansoh Pharmaceutical
    • 11.4.1 Jiangsu Hansoh Pharmaceutical Corporation Information
    • 11.4.2 Jiangsu Hansoh Pharmaceutical Overview
    • 11.4.3 Jiangsu Hansoh Pharmaceutical Tigecycline Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.4.4 Jiangsu Hansoh Pharmaceutical Tigecycline Product Description
    • 11.4.5 Jiangsu Hansoh Pharmaceutical Related Developments
  • 11.5 Abbott
    • 11.5.1 Abbott Corporation Information
    • 11.5.2 Abbott Overview
    • 11.5.3 Abbott Tigecycline Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.5.4 Abbott Tigecycline Product Description
    • 11.5.5 Abbott Related Developments
  • 11.6 Natco Pharma
    • 11.6.1 Natco Pharma Corporation Information
    • 11.6.2 Natco Pharma Overview
    • 11.6.3 Natco Pharma Tigecycline Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.6.4 Natco Pharma Tigecycline Product Description
    • 11.6.5 Natco Pharma Related Developments
  • 11.7 Lyka Labs Limited
    • 11.7.1 Lyka Labs Limited Corporation Information
    • 11.7.2 Lyka Labs Limited Overview
    • 11.7.3 Lyka Labs Limited Tigecycline Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.7.4 Lyka Labs Limited Tigecycline Product Description
    • 11.7.5 Lyka Labs Limited Related Developments
  • 11.8 Fresenius Kabi
    • 11.8.1 Fresenius Kabi Corporation Information
    • 11.8.2 Fresenius Kabi Overview
    • 11.8.3 Fresenius Kabi Tigecycline Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.8.4 Fresenius Kabi Tigecycline Product Description
    • 11.8.5 Fresenius Kabi Related Developments
  • 11.9 Sandoz
    • 11.9.1 Sandoz Corporation Information
    • 11.9.2 Sandoz Overview
    • 11.9.3 Sandoz Tigecycline Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.9.4 Sandoz Tigecycline Product Description
    • 11.9.5 Sandoz Related Developments
  • 11.10 APOTEX
    • 11.10.1 APOTEX Corporation Information
    • 11.10.2 APOTEX Overview
    • 11.10.3 APOTEX Tigecycline Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.10.4 APOTEX Tigecycline Product Description
    • 11.10.5 APOTEX Related Developments
  • 11.1 Pfizer (Wyeth)
    • 11.1.1 Pfizer (Wyeth) Corporation Information
    • 11.1.2 Pfizer (Wyeth) Overview
    • 11.1.3 Pfizer (Wyeth) Tigecycline Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.1.4 Pfizer (Wyeth) Tigecycline Product Description
    • 11.1.5 Pfizer (Wyeth) Related Developments
  • 11.12 Amneal Pharmaceuticals
    • 11.12.1 Amneal Pharmaceuticals Corporation Information
    • 11.12.2 Amneal Pharmaceuticals Overview
    • 11.12.3 Amneal Pharmaceuticals Tigecycline Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.12.4 Amneal Pharmaceuticals Product Description
    • 11.12.5 Amneal Pharmaceuticals Related Developments

12 Value Chain and Sales Channels Analysis

  • 12.1 Tigecycline Value Chain Analysis
  • 12.2 Tigecycline Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Tigecycline Production Mode & Process
  • 12.4 Tigecycline Sales and Marketing
    • 12.4.1 Tigecycline Sales Channels
    • 12.4.2 Tigecycline Distributors
  • 12.5 Tigecycline Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

  • 13.1 Tigecycline Industry Trends
  • 13.2 Tigecycline Market Drivers
  • 13.3 Tigecycline Market Challenges
  • 13.4 Tigecycline Market Restraints

14 Key Findings in The Global Tigecycline Study

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Author Details

    Tigecycline market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Tigecycline market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

    Segment by Type
    Original Drug
    Generic Drug

    Segment by Application
    Hospital Pharmacies
    Retail Pharmacies

    By Company
    Pfizer (Wyeth)
    Sino Biopharmaceutical
    Zhejiang Hisun Pharma
    Jiangsu Hansoh Pharmaceutical
    Abbott
    Natco Pharma
    Lyka Labs Limited
    Fresenius Kabi
    Sandoz
    APOTEX
    Accord Healthcare
    Amneal Pharmaceuticals

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia

    Buy now